TOMS Capital Investment Management LP acquired a new stake in shares of CVS Health Co. (NYSE:CVS – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,940,000 shares of the pharmacy operator’s stock, valued at approximately $121,987,000. CVS Health comprises 4.5% of TOMS Capital Investment Management LP’s holdings, making the stock its 4th largest position.
A number of other institutional investors have also modified their holdings of CVS. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health in the 3rd quarter valued at about $32,000. First Community Trust NA increased its stake in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health in the 3rd quarter worth about $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on CVS shares. Deutsche Bank Aktiengesellschaft lowered their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Piper Sandler lowered their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. Barclays lowered their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Finally, Royal Bank of Canada lowered their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $70.33.
CVS Health Trading Down 0.2 %
CVS opened at $59.85 on Monday. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25. The stock has a market capitalization of $75.32 billion, a PE ratio of 15.19, a P/E/G ratio of 1.02 and a beta of 0.55. The business’s 50 day moving average price is $59.36 and its 200 day moving average price is $58.77. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.
CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 earnings per share. As a group, equities research analysts expect that CVS Health Co. will post 5.37 EPS for the current year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.44%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is 67.51%.
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- Stock Splits, Do They Really Impact Investors?
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What is the NASDAQ Stock Exchange?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What is the Euro STOXX 50 Index?
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.